Determining Patterns In Study Experiences of Neuroblastoma Patients

N/ANot Yet RecruitingNCT05918432

Power Life Sciences Inc.500 enrolled

Overview

Historically, participation in clinical research is highly skewed towards particular demographic groups of people. This study will invite several participants to gather a wide range of information on clinical trial experiences for neuroblastoma patients. The aim of the study is to identify the factors that limit the ability of a person to enroll in, as well as complete a clinical trial for treatment of neuroblastoma. The data collected from this study will help improve future outcomes for all neuroblastoma patients as well as those in under-represented demographic groups.

Study Type

OBSERVATIONAL

Enrollment

500

Conditions

Neuroblastoma

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Confirmed diagnosis of neuroblastoma * Aged ≥ 18 years old and ability to provide written informed consent obtained prior to participation in the study and any related procedures being performed * Subjects willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examination. Exclusion Criteria: * Women of childbearing potential without a negative pregnancy test; or women who are lactating. * Any serious and/or unstable pre-existing medical disorders * Enrolled in another research study

Locations (1)

Power Life Sciences

San Francisco, California, United States

Outcomes

Primary Outcomes

Number of patients who decide to enroll in a neuroblastoma clinical trial

Time frame: 3 months

Rate of patients who remain in neuroblastoma clinical trial to trial completion

Time frame: 12 months

Central Contacts

Michael B Gill

CONTACT

(415) 900-4227 bask@withpower.com

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.